Moderate or severe valvular heart disease and outcomes in allogeneic stem cell transplantation

A Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) was previously developed showing that multiple comorbidities including moderate or greater valvular heart disease to be predictors of non-relapse mortality after allogeneic HCT. However, detailed description of the impact of valve disease on outcomes is lacking.

Source: International Journal of Cardiology - May 23, 2019 Category: Cardiology Authors: Robin M. Brusen, Richard K. Cheng, Sophia C. Masri, Douglas Leedy, Mohamed L. Sorror Source Type: research